Pseudomonas aeruginosa infections have become more challenging to treat and eradicate due to their ability to form biofilms. This study aimed to produce hydrophobic nanoparticles by grafting 11-carbon and three-carbon alkyl chains to a chitosan polymer as a platform to carry and deliver carvacrol for improving its antibacterial and antibiofilm properties. Carvacrol–chitosan nanoparticles showed ζ potential values of 10.5–14.4 mV, a size of 140.3–166.6 nm, and an encapsulation efficiency of 25.1–68.8%. Hydrophobic nanoparticles reduced 46–53% of the biomass and viable cells (7–25%) within P. aeruginosa biofilms. Diffusion of nanoparticles through the bacterial biofilm showed a higher penetration of nanoparticles created with 11-carbon chain chitosan than those formulated with unmodified chitosan. The interaction of nanoparticles with a 50:50 w/w phospholipid mixture at the air–water interface was studied, and values suggested that viscoelasticity and fluidity properties were modified. The modified nanoparticles significantly reduced viable P. aeruginosa in biofilms (0.078–2.0 log CFU·cm−2) and swarming motility (40–60%). Furthermore, the formulated nanoparticles reduced the quorum sensing in Chromobacterium violaceum. This study revealed that modifying the chitosan polarity to synthesize more hydrophobic nanoparticles could be an effective treatment against P. aeruginosa biofilms to decrease its virulence and pathogenicity, mainly by increasing their ability to interact with the membrane phospholipids and penetrate preformed biofilms.
1 October 2018 in Materials Science and Engineering: C
The objective of this study is to establish the ability of entrap allyl isothiocyanate (AITC) into polymeric nanoparticles to extend its shelf life and enhance its antiproliferative properties. Natural compounds, such as AITC, have showed multi-targeting activity resulting in a wide-range spectrum of therapeutic properties in chronic and degenerative diseases, conversely with most current pharmaceutical drugs showing single targeting activity and often result in drug resistance after extended administration periods. Apparently, AITC-loaded poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) reduced AITC degradation and volatility and were able to extend AITC shelf life compared with free AITC (65% vs. 20% in 24 h, respectively). Cell viability and uptake of AITC-loaded nanoparticles were studied in vitro, showing that the protection and sustained release of AITC from polymeric NPs involved a larger toxicity of tumoral cells. These nanoparticles could be used as protective systems for enhancing a biological activity.
El daño por Fusarium oxysporum en las plantas de tomate es de gran importancia económica en todo el mundo debido a las importantes pérdidas que genera en el cultivo. Los avances en nanotecnología proporcionan alternativas que pueden aplicarse en el control de patógenos. Las nanopartículas de plata (AgNP) estabilizadas con quitosano (Cs) tienen actualmente un uso generalizado para el control de patógenos de plantas. El objetivo de la presente investigación fue determinar el efecto de la aplicación de AgNP-Cs sobre la tolerancia de plántulas de tomate y control de la marchitez vascular, provocada por el fitopatógeno. Los resultados mostraron que la aplicación de las NPs no mostró efectos negativos en el desarrollo vegetativo normal de las plántulas de tomate (hasta 2000 ppm). Las nanoestructuras fueron significativamente efectivas para inhibir el crecimiento del micelio hasta en más del 70%, además el tratamiento fue eficaz para reducir la gravedad de la enfermedad en plántulas inoculadas con Fusarium oxysporum después de 14 días post-inoculación.
1 September 2017 in Chilean journal of agricultural research
In this work, we report the synthesis, characterization and biological evaluation of a multifunctional hybrid biocompatible nanoplatform consisting of a biodegradable poly(lactic-co-glycolic acid) (PLGA) matrix functionalized with a polyvinyl alcohol/chitosan mixed surface layer, and co-loaded with superparamagnetic iron oxide nanoparticles (SPIONs) and the anticancer drug cisplatin. In this manner, problems associated with cisplatin low aqueous solubility are precluded as well as a sustained controlled release of the drug is obtained. The hybrid nanoplatforms displayed slightly positive charges and spherical shapes, with an average diameter of ca. 100 nm and very low polydispersity. This size range makes these particles suitable a priori to avoid extensive macrophage recognition whilst ensures exploitation of passive targeting in tumoral cells by the enhanced permeation and retention effect (EPR) and successful interaction with cell surfaces. SPIONs and drug loading extents were determined by inductively coupled plasma mass spectrometry (ICP-MS) and UV-Vis absorption spectroscopy, respectively. The presence of the magnetic nanoparticle in the hybrid platform should enable their intended use as T2 imaging contrast agents as denoted from magnetic imaging measurements in vitro. Furthermore, in-vitro release profiles of cisplatin from nanoplatform showed an initial burst release of about 16% in the first 6 hours, followed by a sustained release over 10 days ensuring a slow delivery of the drug in the site of action to enhance chemotherapeutic activity. This was confirmed by In-vitro cytotoxicity assays denoting that the chemotherapeutic effect of cisplatin on both cervical HeLa and breast MDA-MB-231 cancer cell lines is largely improved when encapsulated in the nanoplatform. Thus, the present characterization and in vitro biological evaluation data indicate that this nanoplatform can be considered as a promising theragnostic nanoplatform for combined imaging and therapy of several tumors. Moreover, its design using different biocompatible materials approved by regulatory agencies might open further expectatives to clinical translation once performing additional in vivo experiments currently on development.